Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3347480
Max Phase: Preclinical
Molecular Formula: C39H52BN5O5
Molecular Weight: 681.69
Molecule Type: Small molecule
Associated Items:
ID: ALA3347480
Max Phase: Preclinical
Molecular Formula: C39H52BN5O5
Molecular Weight: 681.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CC(C)C)NC(=O)c1cnccn1)B1O[C@@H]2[C@H]3CC[C@H](C3(C)C)[C@]2(C)O1
Standard InChI: InChI=1S/C39H52BN5O5/c1-23(2)18-29(43-37(48)31-22-41-16-17-42-31)35(46)44-30(21-25-12-13-26-10-8-9-11-27(26)20-25)36(47)45-33(19-24(3)4)40-49-34-28-14-15-32(38(28,5)6)39(34,7)50-40/h8-13,16-17,20,22-24,28-30,32-34H,14-15,18-19,21H2,1-7H3,(H,43,48)(H,44,46)(H,45,47)/t28-,29+,30+,32-,33+,34-,39+/m1/s1
Standard InChI Key: ZPCJETCKXFKNQU-GMRPQCPKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 681.69 | Molecular Weight (Monoisotopic): 681.4062 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Trippier PC, McGuigan C. (2010) Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications, 1 (3): [10.1039/C0MD00119H] |
Source(1):